AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) Notes Payables (2018 - 2020)

Updated

AC Immune's Notes Payables was $336,773 in the quarter ended Sep 30, 2020, down 0.7% from $338,994 a year earlier but up 1.1% from the prior quarter.

Analysis

AC Immune (ACIU) Notes Payables (2018 - 2020) Analysis & Trends

As of Dec 31, 2019, Notes Payables at AC Immune came in at $656,409, up 93.3% from the prior year.

  • In earlier years, Notes Payables was $339,540 in the year ended Dec 31, 2018.
  • Quarterly Notes Payables has moved between $333,138 (the quarter ended Jun 30, 2020) and $658,770 (the quarter ended Dec 31, 2019) over five years.
  • Per Business Quant data, ACIU's Notes Payables in the three quarters before the quarter ended Sep 30, 2020 was $333,138 (quarter ended Jun 30, 2020), $334,966 (quarter ended Mar 31, 2020) and $658,770 (quarter ended Dec 31, 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AC Immune 265.55 Mn 265.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 336,773.30
Jun 30, 2020 333,137.61
Mar 31, 2020 334,966.30
Dec 31, 2019 658,770.12
Sep 30, 2019 338,993.75
Dec 31, 2018 333,605.15
API Access

AC Immune Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ACIU&period=max&api_key=YOUR_API_KEY